Endo ERN
Find an expert
Ukraine
Endo ERN
Search
  • Rare Endocrine Conditions

    Endocrine Conditions

    Endo-ERN is focused on 8 main thematic groups (MTGs) which cover rare and/or complex endocrine conditions

    Go to overview

    Categories

    • MTG1Adrenal
    • MTG2Disorders of Calcium & Phosphate Homeostasis
    • MTG3Genetic Disorders of Glucose & Insulin Homeostasis
    • MTG4Genetic Endocrine Tumour Syndromes
    • MTG5Growth & Genetic Obesity Syndromes
    • MTG6Hypothalamic and Pituitary Conditions
    • MTG7Sex Development & Maturation
    • MTG8Thyroid
  • About Us

    About Us

    Endo-ERN is a network of 100+ Reference Centres (RCs) in 27 EU member states+Norway that offers access to clinical experts for patients with rare endocrine conditions.  

    Go to overview

    Who we are

    • About Endo-ERN
    • What we do
    • Reference centres
    • Work packages
    • Project team

    Information

    • Events
    • FAQ
    • Newsletter
    • Contact
    • ERNs
  • For Professionals

    For Professionals

    Endo-ERN is the network for rare endocrine conditions providing healthcare professionals with access to a variety of resources to support patient care.  

    Our Network

    • About Endo-ERN
    • Find a Reference Centre

    Research

    • Registries
    • Publications
    • Clinical Trials

    Support Tools

    • Virtual Consultations
    • Guidelines
    • COVID-19

    Training & Education

    • Webinars
    • Exchange Programme
  • For Members

    For Members

    If you work at a member institution this page will help with your Endo-ERN contributions.  

    Go to overview

    Quick Links

    • Cite Endo-ERN
    • CPMS 2.0
    • GA2026
    • The Journal

    Evaluation

    • Continuous Monitoring Exercise
    • 5-year evaluation
    • HCP Performance System

    Network Participation

    • Event Endorsement
    • Member Survey
    • Webinar Planning
    • MTG Representatives

    Membership Management

    • Update Member Contacts
    • Request Disease Area Expansion
    • Termination Policy
  • For Patients

    For Patients

    Access to rare disease expertise without the need to travel is a core ERN objective.  Our ePAGs contribute to all Endo-ERN activities.  

    Go to overview

    Patient information

    • What are European Reference Networks?
    • Cross-border healthcare
    • Rare endocrine conditions
    • Patient materials

    ePAG information

    • European Patient Advocacy Groups
    • Patient representatives
    • How to become an Endo-ERN ePAG
  • Search
  • Rare Endocrine Conditions
  • About Us
  • For Professionals
  • For Members
  • For Patients
  • Search
  • Rare Endocrine Conditions
  • About Us
  • For Professionals
  • For Members
  • For Patients
  • Search
Endo ERN
Ukraine
Find an expert
Search
/ Publications Overview / Publications Database

Endo-ERN Publications Database

RDD IssuesBack to Publications Overview

Filter list of publications

940 publication(s) found matching the search criteria

Skin manifestations in rare types of diabetes and other endocrine conditions


Author(s): Reschke F, Biester T, von dem Berge T, Jamiolkowski D, Hasse L, Dassie F, Maffei P, Klee K, Kordonouri O, Ott H, Danne T
Affiliated Institution / ERN: Hannoversche Kinderheilanstalt ;
Condition / Disease:
Publication: Endocrine Connections Volume 12: Issue 7 Year: 2023 ORPHAcode / other:
DOI: 10.1530/ec-22-0410 Keywords:
MTG3

Case Report – Multinodular goiter in a patient with Congenital Hypothyroidism and Bannayan-Riley-Ruvalcaba syndrome: the possible synergic role of TPO and PTEN mutation


Author(s): Vincenzi G, Petralia IT, Abbate M, Tarantola G, Meroni SLC, Maggiore R, Mari G, Patricelli MG, Schiavo Lena M, Barera G, Vigone MC
Affiliated Institution / ERN: San Raffaele hospital - Milan ;
Condition / Disease: Congenital Hypothyroidism; Bannayan-Riley-Ruvalcaba syndrome
Publication: Frontiers in Endocrinology v14 Year: 2023 ORPHAcode / other: ORPHA442; ORPHA109
DOI: 10.3389/fendo.2023.1205785 Keywords: PTEN hamartoma tumor syndrome,TPO,case report,congenital hypothyroidism,goiter
MTG8

Outcome of immunotherapy in adrenocortical carcinoma: a retrospective cohort study


Author(s): Remde H, Schmidt-Pennington L, Reuter M, Landwehr L, Jensen M, Lahner H, Kimpel O, Altieri B, Laubner K, Schreiner J, Bojunga J, Kircher S, Kunze CA, Pohrt A, Teleanu M, Hübschmann D, Stenzinger A, Glimm H, Fröhling S, Fassnacht M, Mai K, Kroiss M
Affiliated Institution / ERN: Charité Universitätsmedizin Berlin ;
Condition / Disease: Adrenocortical carcinoma
Publication: European Journal of Endocrinology v188.6 p485-493 Year: 2023 ORPHAcode / other: ORPHA1501
DOI: 10.1093/ejendo/lvad054 Keywords: PD-L1,adverse drug reaction,immune checkpoint inhibitor,mitotane,treatment
MTG1

The clinical characteristics and quality of life of 248 pediatric and adult patients with Congenital Adrenal Hyperplasia


Author(s): Shafaay EA, Aldriweesh MA, Aljahdali GL, Babiker A, Alomar AO, Alharbi KM, Aldalaan H, Alenazi A, Alangari AS, Alsagheir A, Adriaansen BPH, Claahsen – van der Grinten HL, Al Alwan I
Affiliated Institution / ERN: Radboud University Medical Centre Nijmegen ;
Condition / Disease: Congenital Adrenal Hyperplasia
Publication: Frontiers in Endocrinology v14 Year: 2023 ORPHAcode / other: ORPHA418
DOI: 10.3389/fendo.2023.1122435 Keywords: CAH,QOL,ambiguous genitalia,psychosocial,virilization
MTG1

RET Proto-Oncogene Variants in Patients with Medullary Thyroid Carcinoma from the Mediterranean Basin: A Brief Report


Author(s): Neocleous V, Fanis P, Frangos S, Skordis N, Phylactou LA
Affiliated Institution / ERN: Cyprus Institute of Neurology and Genetics ;
Condition / Disease: Multiple Endocrine Neoplasia 2, medullary thyroid cancer
Publication: Life v13.6 p1332 Year: 2023 ORPHAcode / other: ORPHA247698; ORPHA247709
DOI: 10.3390/life13061332 Keywords: MEN2,Mediterranean Basin,RET proto-oncogene,medullary thyroid carcinoma
MTG4

RET Proto-Oncogene Variants in Patients with Medullary Thyroid Carcinoma from the Mediterranean Basin: A Brief Report


Author(s): Neocleous V, Fanis P, Frangos S, Skordis N, Phylactou LA
Affiliated Institution / ERN: Cyprus Institute of Neurology and Genetics ;
Condition / Disease: Multiple endocrine neoplasia type 2
Publication: Life v13.6 p1332 Year: 2023 ORPHAcode / other: ORPHA653
DOI: 10.3390/life13061332 Keywords: MEN2,Mediterranean Basin,RET proto-oncogene,medullary thyroid carcinoma
MTG4

Identification of novel compound heterozygous variants in the SLC30A7 (ZNT7) gene in two French brothers with stunted growth, testicular hypoplasia and bone marrow failure


Author(s): Huang L, Yang Z, Kirschke CP, Prouteau C, Copin M, Bonneau D, Pellier I, Coutant R, Miot C, Ziegler A
Affiliated Institution / ERN: CHU d'Angers ;
Condition / Disease: stunted growth, testicular hypoplasia and bone marrow failure
Publication: Human Molecular Genetics v32.12 p2016-2031 Year: 2023 ORPHAcode / other: ORPHA90692
DOI: 10.1093/hmg/ddad033 Keywords:
MTG5

Psychological Care for Children and Adolescents with Diabetes and Patient Outcomes: Results from the International Pediatric Registry SWEET


Author(s): Chobot A, Eckert AJ, Biester T, Corathers S, Covinhas A, de Beaufort C, Imane Z, Kim J, Malatynska A, Moravej H, Pokhrel S, Skinner T, Study Group S
Affiliated Institution / ERN: Centre Hospitalier de Luxembourg ;
Condition / Disease: diabetes type 1
Publication: Pediatric Diabetes v2023 p1-9 Year: 2023 ORPHAcode / other:
DOI: 10.1155/2023/8578231 Keywords:
MTG3

Growth response of syndromic versus non-syndromic children born small for gestational age (SGA) to growth hormone therapy: a Belgian study


Author(s): Becker M, Thomas M, Brachet C, Heinrichs C, Dotremont H, De Schepper J, Lysy P, Beckers D
Affiliated Institution / ERN: Centre Hospitalier de Luxembourg ;
Condition / Disease: growth hormone deficiency (GHD)
Publication: Frontiers in Endocrinology v14 Year: 2023 ORPHAcode / other: ORPHA631; ORPHA101957
DOI: 10.3389/fendo.2023.1112938 Keywords: adult height,children,growth,growth hormone,short for gestational age,short stature,syndromic
MTG5 MTG6

Screening of lipids and kidney function in children and adolescents with Type 1 Diabetes: does age matter?


Author(s): Catamo E, Robino A, Dovc K, Tinti D, Tamaro G, Bonfanti R, Franceschi R, Rabbone I, Battelino T, Tornese G
Affiliated Institution / ERN: University Medical Centre Ljubljana ;
Condition / Disease: diabetes type 1
Publication: Frontiers in Endocrinology v14 Year: 2023 ORPHAcode / other:
DOI: 10.3389/fendo.2023.1186913 Keywords: age,guidelines,kidney function,lipids profile,type 1 diabetes
MTG3

[18F]FDG Uptake and Expression of Immunohistochemical Markers Related to Glycolysis, Hypoxia, and Proliferation in Indeterminate Thyroid Nodules


Author(s): de Koster EJ, van Engen-van Grunsven ACH, Bussink J, Frielink C, de Geus-Oei L, Kusters B, Peters H, Oyen WJG, Vriens D, Netea-Maier RT, Smit JWA, de Wilt JHW, Booij J, Fliers E, Klooker TK, van Dam EWCM, Dreijerink KMA, Raijmakers PGHM, Kam BLR, Peeters RP, Verzijlbergen JF, van Aken MO, Jager PL, Mijnhout GS, van den Hout WB, Arias AMP, Morreau J, Snel M, Dijkhorst-Oei L, de Klerk JMH, Havekes B, Mitea DC, Vöö S, Brouwer CB, van Dam PS, Sivro F, te Beek ET, Jebbink MCW, Bleumink GS, Schelfhout VJR, Keijsers RGM, Wakelkamp IMMJ, Brouwers AH, Links TP, de Keizer B, van Leeuwaarde RS, Bonenkamp JJ, Donders ART, Fütterer JJ
Affiliated Institution / ERN: University Medical Center Utrecht ;
Condition / Disease: Follicular thyroid carcinoma
Publication: Molecular Imaging and Biology v25.3 p483-494 Year: 2023 ORPHAcode / other: ORPHA146
DOI: 10.1007/s11307-022-01776-4 Keywords: Glucose Metabolism,Glycolysis,Immunohistochemistry,Thyroid Nodule,[18F]FDG-PET/CT
MTG8

Clinical course of autoimmune thyroid diseases in women with prolactinomas: Results from a prospective study in a single tertiary centre


Author(s): Elenkova A, Racheva P, Kirilov G, Zacharieva S
Affiliated Institution / ERN: USHATE “ACAD IVAN Penchev” ;
Condition / Disease: Prolactinoma
Publication: Endocrinología, Diabetes y Nutrición (English ed.) v70 p27-34 Year: 2023 ORPHAcode / other: ORPHA2965
DOI: 10.1016/j.endien.2023.05.008 Keywords: Autoimmune thyroiditis,Hipertiroidismo,Hipotiroidismo,Hyperthyroidism,Hypothyroidism,Prolactin,Prolactina,Prolactinoma,Tiroiditis autoinmune
MTG6

Who is sensitising whom? A participatory interview guide development as an awareness tool within a health care research project


Author(s): Kalender U, Wiegmann S, Ernst M, Ihme L, Neumann U, Stöckigt B
Affiliated Institution / ERN: Charité Universitätsmedizin Berlin ;
Condition / Disease:
Publication: Heliyon v9.6 pe16778 Year: 2023 ORPHAcode / other:
DOI: 10.1016/j.heliyon.2023.e16778 Keywords:

Proposal of early CT morphological criteria for response of liver metastases to systemic treatments in gastroenteropancreatic neuroendocrine tumors: Alternatives to RECIST


Author(s): de Mestier L, Resche‐Rigon M, Dromain C, Lamarca A, La Salvia A, de Baker L, Fehrenbach U, Pusceddu S, Colao A, Borbath I, de Haas R, Rinzivillo M, Zerbi A, Funicelli L, de Herder WW, Selberherr A, Wagner AD, Manoharan P, De Cima A, Lybaert W, Jann H, Prinzi N, Faggiano A, Annet L, Walenkamp A, Panzuto F, Pedicini V, Pitoni MG, Siebenhuener A, Mayerhoefer ME, Ruszniewski P, Vullierme M
Affiliated Institution / ERN: AOU Federico II - Naples ;
Condition / Disease: neuroendocrine tumors
Publication: Journal of Neuroendocrinology v35.6 Year: 2023 ORPHAcode / other: ORPHA100092
DOI: 10.1111/jne.13311 Keywords: computed tomography,neuroendocrine tumors,response evaluation,systemic treatments
MTG4

Intermittent Use of Continuous Glucose Monitoring: A New Paradigm in Treatment of Type 2 Diabetes


Author(s): Banshi Saboo, Ranjit Unnikrishnan, Jothydev Kesavadev, Mangesh Tiwaskar, Leszek Czupryniak, Manoj Chawla, Pratik Choudhary, Tadej Battelino, Sanjay Agarwal, Thomas Danne, Viswanathan Mohan
Affiliated Institution / ERN: University Medical Centre Ljubljana ; Hannoversche Kinderheilanstalt ;
Condition / Disease: diabetes type 2
Publication: J Assoc Physicians India 71(6):11-12 Year: 2023 ORPHAcode / other:
DOI: 10.5005/japi-11001-0274 Keywords:
MTG3

Gene expression signature predicts rate of type 1 diabetes progression


Author(s): Suomi T, Starskaia I, Kalim UU, Rasool O, Jaakkola MK, Grönroos T, Välikangas T, Brorsson C, Mazzoni G, Bruggraber S, Overbergh L, Dunger D, Peakman M, Chmura P, Brunak S, Schulte AM, Mathieu C, Knip M, Lahesmaa R, Elo LL, Mathieu C, Gillard P, Casteels K, Overbergh L, Dunger D, Wallace C, Evans M, Thankamony A, Hendriks E, Bruggraber S, Marcoveccchio L, Peakman M, Tree T, Morgan NG, Richardson S, Todd JA, Wicker L, Mander A, Dayan C, Alhadj Ali M, Pieber T, Eizirik DL, Cnop M, Brunak S, Pociot F, Johannesen J, Rossing P, Quigley CL, Mallone R, Scharfmann R, Boitard C, Knip M, Otonkoski T, Veijola R, Lahesmaa R, Oresic M, Toppari J, Danne T, Ziegler AG, Achenbach P, Rodriguez-Calvo T, Solimena M, Bonifacio EE, Speier S, Holl R, Dotta F, Chiarelli F, Marchetti P, Bosi E, Cianfarani S, Ciampalini P, De Beaufort C, Dahl-Jørgensen K, Skrivarhaug T, Joner G, Krogvold L, Jarosz-Chobot P, Battelino T, Thorens B, Gotthardt M, Roep BO, Nikolic T, Zaldumbide A, Lernmark A, Lundgren M, Costacalde G, Strube T, Schulte AM, Nitsche A, Peakman M, Vela J, Von Herrath M, Wesley J, Napolitano-Rosen A, Thomas M, Schloot N, Goldfine A, Waldron-Lynch F, Kompa J, Vedala A, Hartmann N, Nicolas G, van Rampelbergh J, Bovy N, Dutta S, Soderberg J, Ahmed S, Martin F, Latres E, Agiostratidou G, Koralova A, Willemsen R, Smith A, Anand B, Datta V, Puthi V, Zac-Varghese S, Dias R, Sundaram P, Vaidya B, Patterson C, Owen K, Dayan C, Piel B, Heller S, Randell T, Gazis T, Reismen EB, Carel J, Riveline J, Gautier J, Andreelli F, Travert F, Cosson E, Penfornis A, Petit C, Feve B, Lucidarme N, Cosson E, Beressi J, Ajzenman C, Radu A, Greteau-Hamoumou S, Bibal C, Meissner T, Heidtmann B, Toni S, Rami-Merhar B, Eeckhout B, Peene B, Vantongerloo N, Maes T, Gommers L
Affiliated Institution / ERN: Centre Hospitalier de Luxembourg ; Meyer Children’s Hospital Florence ; Assistance Publique-Hôpitaux de Paris, Hôpital Pitié-Salpétrière ;
Condition / Disease: diabetes type 1
Publication: eBioMedicine v92 p104625 Year: 2023 ORPHAcode / other:
DOI: 10.1016/j.ebiom.2023.104625 Keywords: Autoantibodies,Gene expression signature,Predictive model,RNA-seq,Type 1 diabetes
MTG3

The pathogenic p.Gln319Ter variant is not causing congenital adrenal hyperplasia when inherited in one of the duplicated CYP21A2 genes


Author(s): Fanis P, Skordis N, Toumba M, Picolos M, Tanteles GA, Neocleous V, Phylactou LA
Affiliated Institution / ERN: Cyprus Institute of Neurology and Genetics ;
Condition / Disease: Congenital Adrenal Hyperplasia
Publication: Frontiers in Endocrinology v14 Year: 2023 ORPHAcode / other: ORPHA418
DOI: 10.3389/fendo.2023.1156616 Keywords: 21-hyrdroxylase deficiency,CAH,CYP21A2,RCCX,gene duplications
MTG1

Plasma-free metanephrines, nerve growth factor, and renalase significance in patients with PCOS


Author(s): Robeva R, Elenkova A, Kirilov G, Zacharieva S
Affiliated Institution / ERN: USHATE “ACAD IVAN Penchev” ;
Condition / Disease: PCOS
Publication: Endocrine v81.3 p602-612 Year: 2023 ORPHAcode / other:
DOI: 10.1007/s12020-023-03404-9 Keywords: Nerve growth factor (NGF),Normetanephrine,Polycystic ovarian syndrome (PCOS),Renalase,Sympathetic noradrenergic activity
MTG7

Prolyl Endopeptidase-like Deficiency Associated with Growth Hormone Deficiency


Author(s): Sayol-Torres L, Valenzuela MI, Tomasini R, Fernández-Alvarez P, Clemente M, Yeste D
Affiliated Institution / ERN: Hospital Universitari Vall d’Hebron ;
Condition / Disease: Non-acquired pituitary hormone deficiency
Publication: Journal of Clinical Research in Pediatric Endocrinology v15.2 p205-209 Year: 2023 ORPHAcode / other: ORPHA95488
DOI: 10.4274/jcrpe.galenos.2021.2021.0128 Keywords: Prolyl endopeptidase-like,genetics,growth hormone deficiency
MTG6

Current Treatments for Patients with Genetic Obesity


Author(s): Faccioli N, Poitou C, Clément K, Dubern B
Affiliated Institution / ERN: Assistance Publique-Hôpitaux de Paris, Hôpital Pitié-Salpétrière ;
Condition / Disease: Genetic non-syndromic obesity, leptin/melanocortin pathway
Publication: Journal of Clinical Research in Pediatric Endocrinology v15.2 p108-119 Year: 2023 ORPHAcode / other: ORPHA77828
DOI: 10.4274/jcrpe.galenos.2023.2023-3-2 Keywords: Genetic obesity,syndromic obesity,personalized medicine,setmelanotide
MTG5

What is the role of CHCHD2 in adrenal tumourigenesis?


Author(s): Karapanagioti A, Nasiri-Ansari N, Moustogiannis A, Trigas GC, Zografos G, Aggeli C, Kyriakopoulos G, Choreftaki T, Philippou A, Kaltsas G, Kassi E, Angelousi A
Affiliated Institution / ERN: General Hospital of Athens “LAIKO” ;
Condition / Disease: Adrenocortical carcinoma
Publication: Endocrine v81.2 p357-367 Year: 2023 ORPHAcode / other: ORPHA1501
DOI: 10.1007/s12020-023-03393-9 Keywords: Adrenal adenomas,Adrenocortical carcinoma,Apoptosis,BAX,BCL2,CHCHD2
MTG1

Quality of life in children and adolescents with growth hormone deficiency and their caregivers: an Italian survey


Author(s): Maghnie M, Orso M, Polistena B, Cappa M, Pozzobon G, d’Angela D, Patti G, Spandonaro F, Granato S, Di Virgilio R, La Torre D, Salerno M
Affiliated Institution / ERN: San Raffaele hospital - Milan ;
Condition / Disease: growth hormone deficiency
Publication: Journal of Endocrinological Investigation v46.12 p2513-2523 Year: 2023 ORPHAcode / other: ORPHA631; ORPHA101957;
DOI: 10.1007/s40618-023-02106-3 Keywords: Children,Growth hormone deficiency,Italy,Quality of life,Survey
MTG7

Child and adolescent obesity


Author(s): Lister NB, Baur LA, Felix JF, Hill AJ, Marcus C, Reinehr T, Summerbell C, Wabitsch M
Affiliated Institution / ERN: Ulm University Medical Center ;
Condition / Disease: Child and adolescent obesity
Publication: Nature Reviews Disease Primers v9.1 Year: 2023 ORPHAcode / other: ORPHA77828
DOI: 10.1038/s41572-023-00435-4 Keywords:
MTG5

Novel Insulin-Like Growth Factor 1 Gene Mutation: Broadening of the Phenotype and Implications for Insulin Resistance


Author(s): Giacomozzi C, Martin A, Fernández MC, Gutiérrez M, Iascone M, Domené HM, Dominici FP, Bergadá I, Cangiano B, Persani L, Pennisi PA
Affiliated Institution / ERN: AOU-Bologna ;
Condition / Disease: growth hormone deficiency (GHD)
Publication: The Journal of Clinical Endocrinology & Metabolism v108.6 p1355-1369 Year: 2023 ORPHAcode / other: ORPHA101957; ORPHA95488
DOI: 10.1210/clinem/dgac738 Keywords: IGF1 mutation,IGF1 primary insufficiency,impaired glucose tolerance,insulin resistance,short stature
MTG5 MTG6

Bilateral inferior petrosal sinus sampling with human CRH stimulation in ACTH-dependent Cushing’s syndrome: results from a retrospective multicenter study


Author(s): Detomas M, Ritzel K, Nasi-Kordhishti I, Schernthaner-Reiter MH, Losa M, Tröger V, Altieri B, Kroiss M, Kickuth R, Fassnacht M, Micko A, Honegger J, Reincke M, Deutschbein T
Affiliated Institution / ERN: University Hospital Würzburg ;
Condition / Disease: Cushing Syndrome
Publication: European Journal of Endocrinology v188.5 p448-456 Year: 2023 ORPHAcode / other: ORPHA647758; ORPHA189427; ORPHA314749;
DOI: 10.1093/ejendo/lvad050 Keywords: Catheter,Cushing’s disease,IPSS,ectopic,petrosal sinus,pituitary,prolactin
MTG1

Individuals with numerical and structural variations of sex chromosomes: interdisciplinary management with focus on fertility potential


Author(s): Juul A, Gravholt CH, De Vos M, Koledova E, Cools M
Affiliated Institution / ERN: Aarhus University Hospital ;
Condition / Disease: DSD
Publication: Frontiers in Endocrinology v14 Year: 2023 ORPHAcode / other: ORPHA325546
DOI: 10.3389/fendo.2023.1160884 Keywords: DSD,Klinefelter syndrome,NSVSC,Turner syndrome,sex chromosomes
MTG7

Adipose tissue function and insulin sensitivity in syndromic obesity of Bardet-Biedl syndrome


Author(s): Baig S, Wanninayake S, Foggensteiner L, Elhassan YS, Manolopoulos K, Ali S, Lassen PB, Clément K, Steeds RP, Tomlinson JW, Geberhiwot T
Affiliated Institution / ERN: Assistance Publique-Hôpitaux de Paris, Hôpital Pitié-Salpétrière ;
Condition / Disease: BBS
Publication: International Journal of Obesity v47.5 p382-390 Year: 2023 ORPHAcode / other: ORPHA110
DOI: 10.1038/s41366-023-01280-x Keywords:
MTG5

Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants


Author(s): Taïeb D, Wanna GB, Ahmad M, Lussey-Lepoutre C, Perrier ND, Nölting S, Amar L, Timmers HJLM, Schwam ZG, Estrera AL, Lim M, Pollom EL, Vitzthum L, Bourdeau I, Casey RT, Castinetti F, Clifton-Bligh R, Corssmit EPM, de Krijger RR, Del Rivero J, Eisenhofer G, Ghayee HK, Gimenez-Roqueplo A, Grossman A, Imperiale A, Jansen JC, Jha A, Kerstens MN, Kunst HPM, Liu JK, Maher ER, Marchioni D, Mercado-Asis LB, Mete O, Naruse M, Nilubol N, Pandit-Taskar N, Sebag F, Tanabe A, Widimsky J, Meuter L, Lenders JWM, Pacak K
Affiliated Institution / ERN: University Medical Center Groningen ;
Condition / Disease: Phaeochromocytoma and paraganglioma
Publication: The Lancet Diabetes & Endocrinology v11.5 p345-361 Year: 2023 ORPHAcode / other: ORPHA276621
DOI: 10.1016/s2213-8587(23)00038-4 Keywords:
MTG1

Novel therapeutics in rare genetic obesities: A narrative review


Author(s): Dubern B, Faccioli N, Poitou C, Clément K
Affiliated Institution / ERN: Assistance Publique-Hôpitaux de Paris, Hôpital Pitié-Salpétrière ;
Condition / Disease: obesity associated with defect in leptin/melanocortin pathway
Publication: Pharmacological Research v191 p106763 Year: 2023 ORPHAcode / other: ORPHA77828
DOI: 10.1016/j.phrs.2023.106763 Keywords: Childhood obesity,Genetics,Hypothalamus,Melanocortins,Monogenic obesity
MTG5

Epidemiology and diagnostic trends of congenital adrenal hyperplasia in Denmark: a retrospective, population-based study


Author(s): Berglund A, Ornstrup MJ, Lind-Holst M, Dunø M, Bækvad-Hansen M, Juul A, Borch L, Jørgensen N, Rasmussen ÃK, Andersen M, Main KM, Hansen D, Gravholt CH
Affiliated Institution / ERN: Aarhus University Hospital ;
Condition / Disease: Congenital Adrenal Hyperplasia
Publication: The Lancet Regional Health - Europe v28 p100598 Year: 2023 ORPHAcode / other: ORPHA418
DOI: 10.1016/j.lanepe.2023.100598 Keywords: Congenital adrenal hyperplasia,Diagnosis age,Epidemiology,Incidence,Prevalence
MTG1
Page 11 of 32« First«...910111213...2030...»Last »

Endo-ERN Newsletter

Subscribe to our newsletter to receive updates on all network activities and new resources. As soon as you subscribe you will receive an email asking you to confirm your registration.

SIGN UP NOW

News

  • All news
  • Newsletter signup

Events

  • Upcoming events
  • Webinars

Information

  • About Us
  • Contact
  • FAQs

Social Links

Linkedin Facebook Youtube

Contact

Endo-ERN
Coordinating Center
Meibergdreef 9
1105 AZ AMSTERDAM
The Netherlands

info@endo-ern.eu
Funded by the European Union
©2026. All Rights Reserved. Endo-ERN

Privacy Policy – GDPR

Website design by Elan Creative

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Information video for patients and healthcare professionals

Type and Press “enter” to Search

Search
Privacy Overview
Endo-ERN

Endo-ERN Privacy Policy

Endo-ERN is committed to user’s privacy and does not track personal data when visiting our website. We act in accordance with Regulation 2016/679 of the European Parliament and of the Council.

‘Personal data’ means any information relating to an identified or identifiable natural person. An identifiable natural person is one who can be identified, directly or indirectly, in particular by reference to an identifier such as:

  • a name
  • an identification number
  • location data
  • an online identifier or to one or more factors specific to the physical, physiological, genetic, mental, economic, cultural or social identity of that natural person

Cookies

Endo-ERN only tracks anonymised data for statistical purposes. We do this via analytical cookies, placed through an anonymous IP Google analytics tag. The purpose of these cookies are to track the efficiency and success of the website.

These cookies do not store any personal data that can be linked to a natural person, but may save data such as inter alia, data about the website from which a person has come (the so-called referrer), which sub-pages were visited, or how often and for what duration a sub-page was viewed. The data collected through this is general data only, and cannot be traced back to one person.

It is possible to prevent the setting of cookies, by means of a setting of the Internet browser used. On top of that, already set cookies may be deleted at any time via an Internet browser or other software programs. This is possible in all popular Internet browsers.

Google Analytics does not share any data with third parties.

The principles of data protection do not apply to anonymous information and because these cookies minimally impact the privacy of the user, it is not necessary to ask for permission to use these cookies.

Newsletter

You may always unsubscribe from our newsletter at any time through the unsubscribe button located in our newsletter. Endo-ERN is both the controller and responsible for processing of any data regarding the newsletter. Endo-ERN does not make use of a third party for the Newsletter service.

E-services

Endo-ERN has a contact form, which activates your email software and allows you to send a comment or question to a general email address. When you send such a message, your personal data is collected only to the extent necessary to reply. If the team responsible for the mailbox is unable to answer your question, or your questions has regards to another party, it might forward your email to another service.

If you have any questions about the processing of your email and related personal data, do not hesitate to include them in your message.

The collected personal data and all information related to the above mentioned consultation is stored on the email server of the Endo-ERN Coordinating office and potentially those who have been concerned in the correspondence in order to respond to your comment.

Newsletter Tracking

The Endo-ERN newsletter makes use of tracking in order to be able to conduct a statistical analysis of the success or failure of online marketing campaigns. Endo-ERN may see if an email containing a newsletter was opened by a user, when it was opened, and which links were opened. 
The data collected through this tracking is generated and stored by Endo-ERN and is not shared with third parties, but may be used to adapt future content of newsletters in order to better meet the interests of our subscribers.

Contact details

For any questions regarding our privacy policy, please contact the Endo-ERN coordinating office.

You have the right to be forgotten and removed completely from the Endo-ERN contact database. To request this, please contact the Endo-ERN coordinating office.

Endo-ERN Coordinating Center, Meibergdreef 9, 1105 AZ  AMSTERDAM. The Netherlands

 info@endo-ern.eu
Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Powered by  GDPR Cookie Compliance